Amended Statement of Beneficial Ownership (3/a)
2019年12月3日 - 4:11AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
ZEN Wei Peu |
2. Date of Event Requiring Statement (MM/DD/YYYY)
7/17/2019
|
3. Issuer Name and Ticker or Trading Symbol
Emmaus Life Sciences, Inc. [EMMA]
|
(Last)
(First)
(Middle)
21250 HAWTHORNE BLVD., SUITE 800 |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Street)
TORRANCE, CA 90503
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY) 7/30/2019
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common stock, $0.001 par value | 1007834 (1) | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | This Form 3/A is being filed to correct the number of shares of common stock beneficially owned directly by the Reporting Person, which was incorrectly reported as 1,007,833 on a Form 3/A filed on October 8, 2019. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
ZEN Wei Peu 21250 HAWTHORNE BLVD., SUITE 800 TORRANCE, CA 90503 | X |
|
|
|
Signatures
|
Wei Peu Zen | | 12/2/2019 |
**Signature of Reporting Person | Date |
Emmaus Life Sciences (NASDAQ:EMMA)
過去 株価チャート
から 2 2025 まで 3 2025
Emmaus Life Sciences (NASDAQ:EMMA)
過去 株価チャート
から 3 2024 まで 3 2025
Real-Time news about Emmaus Life Sciences Inc (ナスダック市場): 0 recent articles
その他のEmmaus Life Sciences, Inc.ニュース記事